1. Lymphokine‐activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites. Issue 5 (18th September 2013) Authors: Jennings, V.A.; Ilett, E.J.; Scott, K.J.; West, E.J.; Vile, R.; Pandha, H.; Harrington, K.; Young, A.; Hall, G.D.; Coffey, M.; Selby, P.; Errington‐Mais, F.; Melcher, A.A. Journal: International journal of cancer Issue: Volume 134:Issue 5(2014:Mar. 01) Page Start: 1091 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lymphokine‐activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites. Issue 5 (18th September 2013) Authors: Jennings, V.A.; Ilett, E.J.; Scott, K.J.; West, E.J.; Vile, R.; Pandha, H.; Harrington, K.; Young, A.; Hall, G.D.; Coffey, M.; Selby, P.; Errington‐Mais, F.; Melcher, A.A. Journal: International journal of cancer Issue: Volume 134:Issue 5(2014:Mar. 01) Page Start: 1091 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗